Improving Outcomes in BRAF-Mutant mCRC Through Screening and Targeted Therapy



In this webcast, expert faculty discuss the role of BRAF and other biomarkers in guiding treatment decisions, the importance of biomarker screening, and how to implement screening results to make appropriate treatment decisions as well as discussion of the side effect profiles of BRAF-specific therapy and effectively managing adverse events. 

This webcast increases educational opportunities to all members of the cancer care team and increase their understanding of the role of BRAF mutations and the role of biomarker testing through the review of the safety and efficacy of approved targeted BRAF-mutant mCRC treatments and development of strategies to anticipate and mitigate side effects from treatments for BRAF-mutant mCRC.

Target Audience

Physicians, oncology nurse practitioners (NPs), physician assistants (PAs), nurse specialists, pharmacists and other health care providers involved in the management of oncology patients. 

Learning Objectives
  1. Describe the role of BRAF mutations in mCRC oncogenesis and prognosis 

  2. Discuss the role of biomarker testing in treating mCRC 

  3. Review the safety and efficacy of approved targeted BRAF-mutant mCRC treatments 

  4. Implement strategies to anticipate and mitigate side effects from treatments for BRAF-mutant mCRC. 

Activity Launch Date - 10/11/21
Expiration Date - 10/11/22

Disclosure of Commercial Support
This activity is supported by an independent educational grant from Pfizer.

Disclosure of Unlabeled Use
Horizon CME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Statement of Independence
Horizon CME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies.  It is the mission of Horizon CME to develop and present educational activities that are timely, fair balanced, scientifically rigorous, and that serve to improve patient outcomes.  To that end, we welcome comments about how to better serve your needs.

Copyright Information
Copyright © 2021 - All rights reserved. This CME-certified program is held as copyrighted by Horizon CME. Through this notice, Horizon CME grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owners.